Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - The Lancet Oncology

Cancer care innovation: The multi-cancer early detection test leaders are implementing for detection

Judith Vacchino on LinkedIn: Multi-cancer early detection test in symptomatic patients referred for…

Early detection of cancer

Incidental detection of FGFR3 fusion via liquid biopsy leading to earlier diagnosis of urothelial carcinoma

A spectroscopic liquid biopsy for the earlier detection of multiple cancer types

Multi-cancer Early Detection Test In Symptomatic Patients, 40% OFF

Circulating cell-free DNA-based multi-cancer early detection: Trends in Cancer

Jeffrey Venstrom, M.D. on LinkedIn: #esmo22

Performance of the WID-qEC test versus sonography to detect uterine cancers in women with abnormal uterine bleeding (EPI-SURE): a prospective, consecutive observational cohort study in the UK - The Lancet Oncology

Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study - The Lancet

Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up, Breast Cancer Research

Full article: Circulating tumor DNA (ctDNA): can it be used as a pan-cancer early detection test?

The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit

ctDNA Tests for Early Cancer Detection - Are We There Yet?

Cells, Free Full-Text